← Back
$KROS All transactions

Keros Therapeutics, Inc.

X

$ Value

$0

Shares

2

Price

$0

Filed

Jun 24

Insider

Name

ADAR1 Capital Management, LLC

Title

CIK

0001940272

Roles

10% Owner

Transaction Details

Transaction Date

2025-06-20

Code

X

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

As the investment manager of ADAR1 Partners, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. | For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Filing Info

Accession No.

0001104659-25-062092

Form Type

4

Issuer CIK

0001664710

ADAR1 Capital Management, LLC's History

Date Ticker Type Value
2025-10-15 KROS $77.9M
2025-10-15 KROS $4.5M
2025-10-15 KROS $13.2M
2025-06-20 KROS X $6K
2025-06-20 KROS X $98K
2025-06-20 KROS X $14K
2025-06-20 KROS X $0
2025-06-20 KROS X $0
2025-06-20 KROS X $0
2025-05-16 KROS E $0

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $12K 2026-04-15
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
2026-04-02
Cho Esther
Chief Legal Officer
2026-02-24